Profound Medical (PROF) Financials

$6.89

$0.09 (1.32%)

As on 04-Sep-2026 16:00EDT

Market cap

$252 Mln

Revenue (TTM)

$19 Mln

P/E Ratio

--

P/B Ratio

5

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-38.88	-23.45	-22.61	-25.80	-22.36
Cash Flow from Investing Activities	--	-0.25	--	--	--	-0.59
Cash from Financing Activities	--	41.86	54.70	1.76	7.03	5.95
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.99	-1.41	-1.03	-1.34	-1.37	-1.48
Cash EPS ($)	--	-1.39	-0.99	-1.28	-1.30	-1.39
Adjusted Book Value ($)	--	2.96	2.34	1.46	2.49	3.88
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.27	-0.91	-1.06	-1.24	-1.08
Free Cash Flow per Share ($)	--	-1.27	-0.91	-1.06	-1.24	-1.10

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-53.15	-50.62	-57.53	-40.35	-33.94
ROE (%)	-46.38	-57.21	-57.79	-68.65	-43.27	-34.52
ROA (%)	-51.46	-32.92	-46.38	-52.72	-37.95	-32.10
EBIT Margin (%)	-177.13	-256.27	-260.47	-387.93	-422.21	-444.16
Net Margin (%)	-171.72	-264.44	-260.45	-396.85	-429.11	-446.66
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	62.18	0.61	0.41	0.08	-0.03	-0.06
EBIT Growth (%)	22.64	-58.51	5.17	1.00	7.60	-45.13
Net Profit Growth (%)	20.60	-63.57	7.31	0.35	6.61	-41.98
EPS Growth (%)	32.81	-0.37	0.23	0.03	0.07	-0.39
Book Value Growth (%)	4.83	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-5.58	-7.31	-6.35	-7.92	-7.60
Price / Book Value	5.00	2.66	3.20	5.81	4.37	2.90
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-5.75	-4.02	-5.62	-6.09	-7.10	-5.85
Close Price ($)	6.65	7.87	7.51	8.49	10.89	11.23
High Price ($)	8.95	7.99	11.42	15.49	11.82	28.97
Low Price ($)	3.76	3.76	6.78	7.50	3.10	10.02
Market Cap ($ Cr)	251.76	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.07	0.08	0.25	0.16	0.02
Short term debt to equity ratio	0.09	0.00	0.03	0.08	0.01	0.00
Current Ratio	6.45	12.52	10.52	6.58	14.82	18.56
Quick Ratio	5.31	11.17	9.64	5.48	12.92	16.78
Interest Coverage	--	--	--	-36.27	-168.80	-459.67

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	50.57	60.20	69.29	101.24	94.96	20.52
Asset Turnover	0.30	0.12	0.18	0.13	0.09	0.07
Receivable days	--	188.50	257.45	345.82	211.96	234.92
Inventory Days	--	651.71	673.51	967.91	765.63	593.10
Payable days	--	131.90	114.90	187.88	259.90	305.43
Cash Conversion Cycle	--	708.30	816.06	1,125.85	717.68	522.59

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.